AstraZeneca scraps £450m vaccine plant after Labour funding cut AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government.
"AstraZeneca remains closely engaged with the government's work to develop our new industrial strategy, and more broadly we continue to have a thriving life sciences sector, worth £108 billion to the economy and providing over 300,000 highly skilled jobs across the country.".
A government spokesperson said a "change in the make-up of the investment" proposed by AstraZeneca had "led to a reduced government grant offer being put forward".
The AstraZeneca spokesperson said that the Speke site "will continue to produce and supply our flu vaccine, for patients in the UK and around the world".
In the same week they talked about growth, Labour seem to have fumbled a deal with AstraZeneca, one of the UK's largest companies and central to the critical life sciences sector.".
